Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer

被引:0
|
作者
Churchill, Timothy W. [1 ]
Smith, Matthew R. [1 ]
Michaelson, M. Dror [2 ]
Lee, Richard J. [2 ]
Guseh, James Sawalla
Wasfy, Meagan M.
Meneely, Erika
Olivier, Kara
Baggish, Aaron L. [3 ]
Saylor, Philip J.
机构
[1] Harvard Med Sch, Cardiovasc Performance Program, Div Cardiol, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med, Dept Med, Boston, MA USA
[3] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland
基金
美国国家卫生研究院;
关键词
CARDIOVASCULAR-DISEASE; MORTALITY;
D O I
10.1016/j.echo.2024.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:706 / 708
页数:3
相关论文
共 50 条
  • [1] Cardiorespiratory fitness and cardiovascular mortality after prolonged androgen deprivation therapy for prostate cancer.
    Gong, Jingyi
    Payne, David
    Caron, Jesse Pittard
    Bay, Camden
    McGregor, Bradley Alexander
    Hainer, Jon
    Partridge, Ann H.
    Neilan, Tomas G.
    Di Carli, Marcelo
    Nohria, Anju
    Groarke, John
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer
    Gong, Jingyi
    Payne, David
    Caron, Jesse
    Bay, Camden P.
    McGregor, Bradley A.
    Hainer, Jon
    Partridge, Ann H.
    Neilan, Tomas G.
    Di Carli, Marcelo
    Nohria, Anju
    Groarke, John D.
    JACC: CARDIOONCOLOGY, 2020, 2 (04): : 553 - 563
  • [3] Metabolic changes in patients with prostate cancer during androgen deprivation therapy
    Mitsuzuka, Koji
    Arai, Yoichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 45 - 53
  • [4] Changes in body composition during androgen deprivation therapy for prostate cancer
    Smith, MR
    Finkelstein, JS
    McGovern, FJ
    Zietman, AL
    Fallon, MA
    Schoenfeld, DA
    Kantoff, PW
    JOURNAL OF UROLOGY, 2002, 168 (01): : 378 - 379
  • [5] Changes in body composition during androgen deprivation therapy for prostate cancer
    Smith, MR
    Finkelstein, JS
    McGovern, FJ
    Zietman, AL
    Fallon, MA
    Schoenfeld, DA
    Kantoff, PW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02): : 599 - 603
  • [6] Changes in Biomarkers of Inflammation and Angiogenesis During Androgen Deprivation Therapy for Prostate Cancer
    Saylor, Philip J.
    Kozak, Kevin R.
    Smith, Matthew R.
    Ancukiewicz, Marek A.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    Jain, Rakesh K.
    Duda, Dan G.
    ONCOLOGIST, 2012, 17 (02): : 212 - 219
  • [7] Osteoporosis during androgen deprivation therapy for prostate cancer
    Smith, MR
    UROLOGY, 2002, 60 (3A) : 79 - 85
  • [8] Androgen deprivation therapy for prostate cancer and the risk of cardiac mortality
    Tsai, Henry K.
    D'Amico, Anthony V.
    Sadetsky, Natalia
    Chen, Ming-Hui
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 125 - 126
  • [9] Immunohistochemical changes in prostate cancer after androgen deprivation therapy
    Bostwick, DG
    MOLECULAR UROLOGY, 2000, 4 (03) : 101 - 106
  • [10] METABOLIC CHANGES IN PATIENTS WITH PROSTATE CANCER WITH ANDROGEN DEPRIVATION THERAPY
    Peshkov, Maxim N.
    Peshkova, Galina P.
    Reshetov, Igor, V
    DIABETES MELLITUS, 2020, 23 (02): : 192 - 200